We systematically analyzed gene expression data from extensive databases, uncovering a notable upregulation of LSM1 in GBM tissues compared to normal brain samples, hinting at its potential as a promising biomarker for assessing disease prognosis. This evidence concerns the gene LSM1 and glioblastoma.